The Interdisciplinary Annotated Psychedelic Research Bibliography of 2023 Post published:February 9, 2024 Post category:2023 Year in Review/Analysis
The Psychedelic Drug Development Pipeline: Bullseye Chart Year-End 2023 Post published:February 6, 2024 Post category:2023 Year in Review/Analysis
Psychedelic Policy Reform & Legal Markets in 2023 Post published:January 30, 2024 Post category:2023 Year in Review/Analysis
Ensuring the Affordable Becomes Accessible – Lessons from Ketamine’s Antidepressant Development and a Vision for More Equitable Drug Development Post published:January 25, 2024 Post category:Analysis/Opinions
European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients Post published:January 24, 2024 Post category:Analysis/News
Psychedelics M&A and Partnerships in 2023 Post published:January 22, 2024 Post category:2023 Year in Review/Analysis
Psychedelic Funding & Public Markets in 2023 Post published:January 18, 2024 Post category:2023 Year in Review/Analysis
Pα+: Knowledge Gaps in Psychedelic Medicalisation, According to ECNP and Regulators Post published:January 17, 2024 Post category:Analysis/Pα+
Reflecting on Psychedelics in 2023 Post published:January 16, 2024 Post category:2023 Year in Review/Analysis
Our Top 10 Psychedelics Articles in 2023 Post published:January 11, 2024 Post category:2023 Year in Review/Analysis